Navigation Links
Not the protein, but its location in the cell, determines the onset of leukemia
Date:7/10/2008

kinase inhibitors are usually used to combat these kinds of cancers. However, the carcinogenic kinase often becomes resistant to these inhibitors − which is certainly true for T-ALL. So, scientists are actively seeking alternative approaches.

De Keersmaecker's recent research results now offer a possibility. Indeed, the scientists have shown in cells that NUP214-ABL1 is no longer carcinogenic when it cannot bind with the protein complex in the vicinity of the cell nucleus. On the basis of these results, the researchers want to further investigate the therapeutic possibilities of compounds that render binding between the complex and NUP214-ABL1 impossible. This study also indicates that the location of proteins can play an important role in other forms of cancer/leukemia as well.


'/>"/>

Contact: Joke Comijn
Joke.comijn@vib.be
329-244-6611
VIB (the Flanders Institute for Biotechnology)
Source:Eurekalert

Page: 1 2

Related biology technology :

1. The PLSG Invests $150,000 in Coventina Healthcare Enterprises, Inc., Its Eighth Company Relocation to Pittsburgh
2. Clinsys Clinical Research, Inc. Announces Relocation of Corporate Headquarters
3. AMDL Signs 100 Strategic Cooperation Agreements in China for Its JPGreen Clinics; Gross Sales Per Each Location Could Exceed $400,000
4. Time Domain Showcases Precision Location Capability of Ultra Wideband PLUS Product Line at HIMSS 2008
5. Surface dislocation nucleation: Strength is but skin deep at the nanoscale, Penn engineers discover
6. Caliper Life Sciences Announces Date and Location of its 2008 Annual Meeting of Stockholders
7. Expansion and Relocation to New, State-Of-The-Art Facilities Marks Milestone in Effort to Roll Out New Tool for Cancer Diagnosis
8. RainDance Announces Company Relocation and Manufacturing Startup
9. Cord Blood America Reports CorCell, Its Major Acquisition in 2006, Turns Profitable
10. Court Determines that University of Pittsburgh and Artecel Have Sole Rights to Adipose-Derived Stem Cell Patent
11. Genzyme Study of Myozyme(R) for Late-Onset Pompe Patients Meets Co-Primary Efficacy Endpoints
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/4/2015)... (PRWEB) March 04, 2015 USDM ... in the life sciences industry, hired David Blewitt ... the Cloud Compliance Services and Solutions at USDM ... cloud based applications while maintaining compliance with government regulations ... has been an accomplished life sciences regulatory and IS ...
(Date:3/4/2015)... (PRWEB) March 04, 2015 ... in Personalized Medicine, is excited to announce the ... Testing to Optimize the Management of Pain”. , ... at Medscape.com for the next year. The focus ... how to recognize inadequate pain treatments, integrate appropriate ...
(Date:3/4/2015)... , March 4, 2015 ... Paris in December 2011, ... of yttrium-90 resin microspheres versus sorafenib in advanced hepatocellular ... expected late 2016.   SARAH, a large ... cancer (hepatocellular carcinoma, or HCC) has completed patient enrolment, ...
(Date:3/3/2015)... astronaut Scott Kelly , who is making final preparations ... and working on the International Space Station, will be available ... Monday, March 9. Kelly will participate from ... of his training. The interviews will be preceded at 5 ... training and previous spaceflights. To schedule an interview, ...
Breaking Biology Technology:USDM Life Sciences Names David Blewitt VP of Cloud Compliance for Regulated Life Sciences 2USDM Life Sciences Names David Blewitt VP of Cloud Compliance for Regulated Life Sciences 3Proove Biosciences Launches CME Accredited Program with Medscape 2Proove Biosciences Launches CME Accredited Program with Medscape 3Treatment of Primary Liver Cancer: SARAH Study Completes Enrolment, Results Expected Late 2016 2Treatment of Primary Liver Cancer: SARAH Study Completes Enrolment, Results Expected Late 2016 3Treatment of Primary Liver Cancer: SARAH Study Completes Enrolment, Results Expected Late 2016 4Treatment of Primary Liver Cancer: SARAH Study Completes Enrolment, Results Expected Late 2016 5NASA Astronaut Scott Kelly Available for Interviews before One-Year Space Station Mission 2
... 9 Aida,Pharmaceuticals, Inc. (OTC Bulletin Board: ... today announced that the Chinese,government has loosened ... throughout China. Aida expects the sales of ... as sales efforts are,pursued nationwide without restriction. ...
... LANSING, Mich., Oct. 9 The Michigan Life ... two new companies designed,to rapidly stimulate significant and ... The Michigan Virtual BioPharma Company, LLC and the ... an exhibit on Tuesday, October,16, 2007, during the ...
... Technology Provides a ,Total Solution, to Orthopedic Imaging, ... announced,that it has received 510k clearance from the Food ... Xray imager in the United States for 2D,imaging use. ... solution to orthopedic imaging,allowing images to be obtained with ...
Cached Biology Technology:Sales of Etimicin Sulfate to Expand Nationwide as Government Restriction is Lifted 2Michigan Life Science Network to Form Two New Virtual Companies 2Michigan Life Science Network to Form Two New Virtual Companies 3FDA Clears Biospace med's Revolutionary Low Dose Xray Imager 2FDA Clears Biospace med's Revolutionary Low Dose Xray Imager 3FDA Clears Biospace med's Revolutionary Low Dose Xray Imager 4
(Date:2/5/2015)... -- New Market Research Reports Title Global ... 2020 has Been Added to GrandViewReseach.com Report Database ... reach USD 5.10 billion by 2020, according to a ... help identify the site of tissue damage in case ... in medical imaging applications. They have been extensively used ...
(Date:1/22/2015)... DUBLIN , Jan. 22, 2015 Research and Markets ... "Biometrics - A Global Market Overview" report to ... biometrics technology is to ensure that an individual is who ... technology may make use of a person,s unique physical characteristics, ...
(Date:1/22/2015)... , Jan. 15, 2015  BellBrook Labs, a leader ... announced the launch of a TR-FRET (time resolved ... Transcreener UDP Assay, a high throughput screening assay ... assay will allow for sensitive detection of hundreds ...
Breaking Biology News(10 mins):IR Camera Market Worth $5.10 Billion By 2020: Grand View Research, Inc. 2IR Camera Market Worth $5.10 Billion By 2020: Grand View Research, Inc. 3Biometrics - A Global Market Overview 2Biometrics - A Global Market Overview 3BellBrook Labs Launches a High Throughput Screening Assay for Glycosyltransferases with TR-FRET Readout 2
... Philadelphia, PA, November 1, 2012 There are a ... are important for the biology of schizophrenia. In a ... Fatj-Vilas and colleagues explored the impact of the interleukin-1β ... Fatj-Vilas said that "this study is a ...
... BiOptix today announced that it would be highlighting the new ... phase-based common path interferometry technology, at the Label Free ... as well as at the PEGS Europe Summit ... Label Free and PEGS Europe meetings, BiOptix will unveil new ...
... by thousands of bacteria and fungi living in ... survive in this diverse environment, plants employ sophisticated ... microorganisms. Here the so-called chitin molecules ... important role as they are detected by the ...
Cached Biology News:Inflammation and cognition in schizophrenia 2BiOptix to highlight new 404pi instrument at European symposia 2Plants recognise pathogenic and beneficial microorganisms 2
Designed for use with all 96-well SPRI reagent kits. Used with round bottom 96-well microplates, and 96-well thermal cycling plates....
... modular, computer controlled pre-amplifier suitable for a ... electrode input for recording physiological signal such ... a transducer input for use with a ... Additional options include a stimulus artefact clamp ...
... be used with all 96-well ... stacking of covered plates ... with automated systems ... are available for use with ...
... for use with 96- or 384-well PCR plates ... of location on 96-tube plates End tabs on ... the plate* Efficient sealing is achieved with either ... screw or clip-down hot lid thermal cyclers Fully ...
Biology Products: